Suchergebnisse - "Pinato, David J"

PubPharm (27)

1

Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types : a systematic review

enthalten in: Journal for immunotherapy of cancer | 2024

von Galle, P. | Finn, R. | Mitchell, C. | +4

2

Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer

enthalten in: Journal for immunotherapy of cancer | 2023

von Naqash, A. | McCallen, J. | Mi, E. | +22

3

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC) : "Real World" Experience

enthalten in: Clinical genitourinary cancer | 2023

von Bakaloudi, D. | Talukder, R. | Lin, G. | +32

4

Diabetes and Immune Checkpoint Inhibitors-Response

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Cortellini, A. | D'Alessio, A. | Pinato, D.

CommentOn: Clin Cancer Res. 2023 Jul 14;29(14):2714-2724. - PMID 37125965

5

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Cortellini, A. | D'Alessio, A. | Cleary, S. | +55

CommentIn: Clin Cancer Res. 2023 Oct 2;29(19):4017-4018. - PMID 37779446

6

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma : An international observational study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Talbot, T. | D'Alessio, A. | Pinter, M. | +33

CommentIn: Liver Int. 2023 Mar;43(3):528-530. - PMID 36808694

7

Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC

enthalten in: JAMA oncology | 2023

von Rakaee, M. | Adib, E. | Ricciuti, B. | +19

CommentIn: JAMA Oncol. 2023 Jan 1;9(1):60-61. - PMID 36394848

8

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer : a joint analysis of OnCovid and ESMO-CoCARE registries

enthalten in: Journal for immunotherapy of cancer | 2022

von Cortellini, A. | Dettorre, G. | Dafni, U. | +40

9

Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer

enthalten in: BJU international | 2022

von Makrakis, D. | Talukder, R. | Diamantopoulos, L. | +44

10

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

enthalten in: Clinical genitourinary cancer | 2022

von Makrakis, D. | Talukder, R. | Lin, G. | +49